Skip to content

A Clinical Study in Subjects with Dental Hyper-Sensitivity

A Prospective, Open-Label, Non-Randomized, Single-Arm, Efficacy and Safety Outcome Clinical Study using â??Dabur Herbâ??l Sensitive Natural Tooth Pasteâ?? in Adult Subjects with Dental Hyper-Sensitivity

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/08/015259
Enrollment
30
Registered
2018-08-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Dabur Herbâ??l Sensitive Natural Tooth Paste: Used twice daily for 30 days

Sponsors

Dabur International Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects of either genders 2. Subjects between age of 18 and 55 (inclusive) years 3. Subjects who are medically/systemically fit 4. Non pregnant females 5. Non-lactating females 6. No history of allergy to oral care consumer products - specifically ingredients of tooth paste 7. Subjects should be a regular user of tooth paste and a tooth brush 8. Subjects willing to give a voluntary written informed consent

Exclusion criteria

Exclusion criteria: 1. Subjects who use mouth washes regularly 2. Subjects with a known history or present condition of hyper sensitivity/allergy to any tooth paste, mouthwash or oral hygiene products 3. Subjects who have used any antibiotic, antimicrobial, analgesic medications, or desensitizing tooth paste during previous 1 month 4. Subjects with partial removable dentures, orthodontic bands, or advanced periodontal disease 5. Subjects with inadequate restorations or untreated dental carries

Design outcomes

Primary

MeasureTime frame
Relief from SensitivityTimepoint: End of 30 days

Secondary

MeasureTime frame
Assessment of SafetyTimepoint: End of 30 days

Countries

India

Contacts

Public ContactNagalakshmi AnandaPadmanabhan

Consortium Clinical Research Pvt. Ltd.

naga@consortiumcr.com9789777777

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026